McCurdy, Sandra
101  results:
Search for persons X
?
 
?
 
?
3

Efficacy of Delafloxacin against the Biothreat Pathogen Bur..:

McCurdy, Sandra ; Duffy, Erin ; Hickman, Mark..
Antimicrobial Agents and Chemotherapy.  65 (2021)  10 - p. , 2021
 
?
 
?
5

Efficacy of delafloxacin versus moxifloxacin against atypic..:

McCurdy, Sandra ; Nenninger, Ashley ; Sheets, Amanda...
International Journal of Infectious Diseases.  97 (2020)  - p. 374-379 , 2020
 
?
6

2230. Analysis of the Microbiological Data from the Delaflo..:

McCurdy, Sandra ; Keedy, Kara ; Lawrence, Laura..
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S761-S762 , 2019
 
?
7

Activity of Delafloxacin When Tested Against Bacterial Surv..:

Flamm, Robert K ; Shortridge, Dee ; Huband, Michael D..
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S373-S374 , 2017
 
?
 
?
11

The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppr..:

Kudlacz, Elizabeth ; Perry, Bret ; Sawyer, Perry...
American Journal of Transplantation.  4 (2004)  1 - p. 51-57 , 2004
 
?
13

2373. Evaluation of Delafloxacin Activity and Treatment Out..:

Shortridge, Dee ; McCurdy, Sandra P ; Rhomberg, Paul R..
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S706-S707 , 2018
 
?
14

Molecular Characterization of Fluoroquinolone Resistance Me..:

Mendes, Rodrigo E ; Shortridge, Dee ; McCurdy, Sandra P...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S131-S131 , 2017
 
?
15

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vanc..:

Overcash, Scott ; O'Riordan, William ; Lawrence, Laura...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S533-S533 , 2017
 
1-15